Pricing Log in Create free account

Incannex Healthcare Inc. (IXHL) vs Zhengye Biotechnology Holding Limited (ZYBT)

Incannex Healthcare Inc. and Zhengye Biotechnology Holding Limited are both Drug Manufacturers Specialty & Generic companies. Zhengye Biotechnology Holding Limited is the larger, with a market value of $44.6M against $36.1M — 1.2× the size. Across the 7 metrics below, Zhengye Biotechnology Holding Limited leads on 4 and Incannex Healthcare Inc. on 3.

Valuation

Metric IXHL ZYBT Drug Manufacturers Specialty & Generic median
P/E n/m — 19.25
P/S 21.06 — 2.11
P/B 0.49 n/m 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA 1.36 n/m 12.58
EV/Sales (19.90) n/m 2.73
Earnings yield (60.71%) — (4.38%)
Free cash flow yield (39.17%) 0.00% 0.00%

Profitability

Metric IXHL ZYBT Drug Manufacturers Specialty & Generic median
Gross margin (0.10%) — 53.94%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (47.80%) 0.00% (0.40%)
Return on assets (41.32%) 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IXHL ZYBT Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — — 10.01%
EPS growth (last fiscal year) 95.91% (800.00%) 49.06%
Revenue growth, 5-year CAGR (29.64%) — 6.74%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric IXHL ZYBT Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.24 0.05
Current ratio 48.81 1.14 2.31
Net debt to EBITDA 2.97 (0.51) 0.97

Dividend

Metric IXHL ZYBT Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric IXHL ZYBT Drug Manufacturers Specialty & Generic median
Market cap 36.12m 44.59m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack